Literature DB >> 16970864

Tourette syndrome: the self under siege.

James F Leckman1, Michael H Bloch, Lawrence Scahill, Robert A King.   

Abstract

Tourette syndrome is a neurodevelopmental disorder characterized by motor and vocal tics--rapid, repetitive, stereotyped movements or vocalizations. Tourette syndrome typically has a prepubertal onset, and boys are more commonly affected than girls. Symptoms usually begin with transient bouts of simple motor tics. By age 10 years, most children are aware of nearly irresistible somatosensory urges that precede the tics. These urges likely reflect a defect in sensorimotor gating because they intrude into the child's conscious awareness and become a source of distraction and distress. A momentary sense of relief typically follows the completion of a tic. Over the course of hours, tics occur in bouts, with a regular intertic interval. Tics increase during periods of emotional excitement and fatigue. Tics can become "complex" in nature and appear to be purposeful. Tics can be willfully suppressed for brief intervals and can be evoked by the mere mention of them. Tics typically diminish during periods of goal-directed behavior, especially those that involve both heightened attention and fine motor or vocal control, as occur in musical and athletic performances. Over the course of months, tics wax and wane. New tics appear, often in response to new sources of somatosensory irritation, such as the appearance of a persistent vocal tic (a cough) following a cold. Over the course of years, tic severity typically peaks between 8 and 12 years of age. By the end of the second decade of life, many individuals are virtually tic free. Less than 20% of cases continue to experience clinically impairing tics as adults. Tics rarely occur in isolation, and other coexisting conditions--such as behavioral disinhibition, hypersensitivity to a broad range of sensory stimuli, problems with visual motor integration, procedural learning difficulties, attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder, depression, anxiety, and emotional instability--are often a greater source of impairment than the tics themselves. Emerging behavioral treatments of Tourette syndrome are based in part on an understanding of the moment-to-moment experience of somatosensory urges and motor response. With identification of specific genes of major effect and advances in our understanding of the neural circuitry of sensorimotor gating, habit formation, and procedural memory--together with insights from postmortem brain studies, in vivo brain imaging, and electrophysiologic recordings--we might be on the threshold of a deeper understanding of the phenomenology and natural history of Tourette syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16970864     DOI: 10.1177/08830738060210081001

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  51 in total

Review 1.  Evidence-based assessment of compulsive skin picking, chronic tic disorders and trichotillomania in children.

Authors:  Joseph F McGuire; Brittany B Kugler; Jennifer M Park; Betty Horng; Adam B Lewin; Tanya K Murphy; Eric A Storch
Journal:  Child Psychiatry Hum Dev       Date:  2012-12

Review 2.  Advances in understanding and treatment of Tourette syndrome.

Authors:  Kevin St P McNaught; Jonathan W Mink
Journal:  Nat Rev Neurol       Date:  2011-11-08       Impact factor: 42.937

3.  L-histidine decarboxylase and Tourette's syndrome.

Authors:  A Gulhan Ercan-Sencicek; Althea A Stillman; Ananda K Ghosh; Kaya Bilguvar; Brian J O'Roak; Christopher E Mason; Thomas Abbott; Abha Gupta; Robert A King; David L Pauls; Jay A Tischfield; Gary A Heiman; Harvey S Singer; Donald L Gilbert; Pieter J Hoekstra; Thomas M Morgan; Erin Loring; Katsuhito Yasuno; Thomas Fernandez; Stephan Sanders; Angeliki Louvi; Judy H Cho; Shrikant Mane; Christopher M Colangelo; Thomas Biederer; Richard P Lifton; Murat Gunel; Matthew W State
Journal:  N Engl J Med       Date:  2010-05-05       Impact factor: 91.245

4.  Exon expression and alternatively spliced genes in Tourette Syndrome.

Authors:  Yingfang Tian; Isaac H Liao; Xinhua Zhan; Joan R Gunther; Bradley P Ander; Dazhi Liu; Lisa Lit; Glen C Jickling; Blythe A Corbett; Netty G P Bos-Veneman; Pieter J Hoekstra; Frank R Sharp
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-17       Impact factor: 3.568

5.  Olanzapine as treatment for children and adolescents with Tourette's syndrome.

Authors:  Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2009-04       Impact factor: 5.285

6.  A cluster analysis of tic symptoms in children and adults with Tourette syndrome: clinical correlates and treatment outcome.

Authors:  Joseph F McGuire; Epiphanie Nyirabahizi; Katharina Kircanski; John Piacentini; Alan L Peterson; Douglas W Woods; Sabine Wilhelm; John T Walkup; Lawrence Scahill
Journal:  Psychiatry Res       Date:  2013-09-27       Impact factor: 3.222

7.  Deep brain stimulation in tourette syndrome: a description of 3 patients with excellent outcome.

Authors:  Rodolfo Savica; Matt Stead; Kenneth J Mack; Kendall H Lee; Bryan T Klassen
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

8.  Association of Tourette Syndrome and Chronic Tic Disorders With Objective Indicators of Educational Attainment: A Population-Based Sibling Comparison Study.

Authors:  Ana Pérez-Vigil; Lorena Fernández de la Cruz; Gustaf Brander; Kayoko Isomura; Andreas Jangmo; Ralf Kuja-Halkola; Eva Hesselmark; Brian M D'Onofrio; Henrik Larsson; David Mataix-Cols
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

9.  Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.

Authors:  Birgitte Bertelsen; Linea Melchior; Lars R Jensen; Camilla Groth; Birte Glenthøj; Renata Rizzo; Nanette Mol Debes; Liselotte Skov; Karen Brøndum-Nielsen; Peristera Paschou; Asli Silahtaroglu; Zeynep Tümer
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

Review 10.  DBS in Tourette syndrome: where are we standing now?

Authors:  Pablo Andrade; Veerle Visser-Vandewalle
Journal:  J Neural Transm (Vienna)       Date:  2016-05-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.